» Articles » PMID: 18098034

Pulmonary Lesions in Female Harlan Sprague-Dawley Rats Following Two-year Oral Treatment with Dioxin-like Compounds

Overview
Journal Toxicol Pathol
Publisher Sage Publications
Date 2007 Dec 22
PMID 18098034
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Dioxin and dioxin-related compounds have been associated with high incidences of pulmonary dysfunctions and/or cancers in humans. To evaluate the relative potencies of effects of these compounds, the National Toxicology Program completed a series of two-year bioassays which were conducted using female Harlan Sprague-Dawley rats. The rats were treated orally for up to 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3',4,4',5-pentachlorobiphenyl (PCB126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), and a ternary mixture of TCDD, PCB126 and PeCDF. In addition to treatment-related effects reported in other organs, a variety of pulmonary lesions were observed that were related to exposure. Pulmonary CYP1A1-associated 7-ethoxyresorufin-O-deethylase (EROD) activity was increased in all dosed groups. The most common non-neoplastic lesions, which occurred in all studies, were bronchiolar metaplasia and squamous metaplasia of the alveolar epithelium. Cystic keratinizing epithelioma was the most commonly observed neoplasm which occurred in all studies. A low incidence of squamous cell carcinoma was associated only with PCB126 treatment. Potential mechanisms leading to altered differentiation and/or proliferation of bronchiolar and alveolar epithelia may be through CYP1A1 induction or disruption of retinoid metabolism.

Citing Articles

Environmental and occupational determinants of lung cancer.

Shankar A, Dubey A, Saini D, Singh M, Prasad C, Roy S Transl Lung Cancer Res. 2019; 8(Suppl 1):S31-S49.

PMID: 31211104 PMC: 6546634. DOI: 10.21037/tlcr.2019.03.05.


Repeated dose toxicity and relative potency of 1,2,3,4,6,7-hexachloronaphthalene (PCN 66) 1,2,3,5,6,7-hexachloronaphthalene (PCN 67) compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for induction of CYP1A1, CYP1A2 and thymic atrophy in female....

Hooth M, Nyska A, Fomby L, Vasconcelos D, Vallant M, Devito M Toxicology. 2012; 301(1-3):85-93.

PMID: 22813907 PMC: 3471150. DOI: 10.1016/j.tox.2012.07.005.


Proceedings of the 2010 National Toxicology Program Satellite Symposium.

Adams E, Auerbach S, Blackshear P, Bradley A, Gruebbel M, Little P Toxicol Pathol. 2010; 39(1):240-66.

PMID: 21177527 PMC: 3096448. DOI: 10.1177/0192623310391680.


Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats.

Bolton S, Pinnion K, Oreffo V, Foster M, Pinkerton K Respir Res. 2009; 10:118.

PMID: 19930705 PMC: 2789729. DOI: 10.1186/1465-9921-10-118.

References
1.
Beebe L, Park S, Anderson L . Differential enzyme induction of mouse liver and lung following a single low or high dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Biochem Toxicol. 1990; 5(4):211-9. DOI: 10.1002/jbt.2570050403. View

2.
. Polychlorinated Dibenzo-Para-Dioxins and Polychlorinated Dibenzofurans. IARC Monogr Eval Carcinog Risks Hum. 1997; 69:1-631. PMC: 5366851. View

3.
Nyska A, Yoshizawa K, Jokinen M, Brix A, Sells D, Wyde M . Olfactory epithelial metaplasia and hyperplasia in female Harlan Sprague-Dawley rats following chronic treatment with polychlorinated biphenyls. Toxicol Pathol. 2005; 33(3):371-7. DOI: 10.1080/01926230590930209. View

4.
Ten Tusscher G, Koppe J . Perinatal dioxin exposure and later effects--a review. Chemosphere. 2003; 54(9):1329-36. DOI: 10.1016/S0045-6535(03)00254-6. View

5.
Lancillotti F, Darwiche N, Celli G, De Luca L . Retinoid status and the control of keratin expression and adhesion during the histogenesis of squamous metaplasia of tracheal epithelium. Cancer Res. 1992; 52(22):6144-52. View